227 related articles for article (PubMed ID: 21308776)
1. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
[TBL] [Abstract][Full Text] [Related]
4. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
5. Increased trabecular bone formation in mice lacking the growth factor midkine.
Neunaber C; Catala-Lehnen P; Beil FT; Marshall RP; Kanbach V; Baranowsky A; Lehmann W; Streichert T; Ignatius A; Muramatsu T; Schinke T; Amling M
J Bone Miner Res; 2010 Aug; 25(8):1724-35. PubMed ID: 20200993
[TBL] [Abstract][Full Text] [Related]
6. Antibody-based inhibition of circulating DLK1 protects from estrogen deficiency-induced bone loss in mice.
Figeac F; Andersen DC; Nipper Nielsen CA; Ditzel N; Sheikh SP; Skjødt K; Kassem M; Jensen CH; Abdallah BM
Bone; 2018 May; 110():312-320. PubMed ID: 29499415
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy.
Lee SK; Kadono Y; Okada F; Jacquin C; Koczon-Jaremko B; Gronowicz G; Adams DJ; Aguila HL; Choi Y; Lorenzo JA
J Bone Miner Res; 2006 Nov; 21(11):1704-12. PubMed ID: 17002560
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
9. Physiological function of the angiotensin AT1a receptor in bone remodeling.
Kaneko K; Ito M; Fumoto T; Fukuhara R; Ishida J; Fukamizu A; Ikeda K
J Bone Miner Res; 2011 Dec; 26(12):2959-66. PubMed ID: 21887703
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice.
Onoe Y; Miyaura C; Ito M; Ohta H; Nozawa S; Suda T
J Bone Miner Res; 2000 Mar; 15(3):541-9. PubMed ID: 10750569
[TBL] [Abstract][Full Text] [Related]
11. Positive regulation of osteogenesis by bile acid through FXR.
Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
[TBL] [Abstract][Full Text] [Related]
12. Prevention of trabecular bone loss induced by estrogen deficiency by a selective p38alpha inhibitor.
Caverzasio J; Higgins L; Ammann P
J Bone Miner Res; 2008 Sep; 23(9):1389-97. PubMed ID: 18442314
[TBL] [Abstract][Full Text] [Related]
13. Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency.
Daci E; Verstuyf A; Moermans K; Bouillon R; Carmeliet G
J Bone Miner Res; 2000 Aug; 15(8):1510-6. PubMed ID: 10934649
[TBL] [Abstract][Full Text] [Related]
14. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
Iwaniec UT; Yuan D; Power RA; Wronski TJ
J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
[TBL] [Abstract][Full Text] [Related]
15. Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6.
Miyaura C; Kusano K; Masuzawa T; Chaki O; Onoe Y; Aoyagi M; Sasaki T; Tamura T; Koishihara Y; Ohsugi Y
J Bone Miner Res; 1995 Sep; 10(9):1365-73. PubMed ID: 7502709
[TBL] [Abstract][Full Text] [Related]
16. Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis.
Usui M; Yoshida Y; Tsuji K; Oikawa K; Miyazono K; Ishikawa I; Yamamoto T; Nifuji A; Noda M
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6653-8. PubMed ID: 15100414
[TBL] [Abstract][Full Text] [Related]
17. Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice.
Hankenson KD; James IE; Apone S; Stroup GB; Blake SM; Liang X; Lark MW; Bornstein P
Matrix Biol; 2005 Aug; 24(5):362-70. PubMed ID: 15979292
[TBL] [Abstract][Full Text] [Related]
18. JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion.
Kawamata A; Izu Y; Yokoyama H; Amagasa T; Wagner EF; Nakashima K; Ezura Y; Hayata T; Noda M
J Cell Biochem; 2008 Mar; 103(4):1037-45. PubMed ID: 18240141
[TBL] [Abstract][Full Text] [Related]
19. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
[TBL] [Abstract][Full Text] [Related]
20. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
